Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mion

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Kidney International|August 1, 1997
Precise quantification of dialysis using continuous sampling of spent dialysate and total dialysate volume measurementA Argilés, A Ficheux, M Thomas, et al.
Shock (Augusta, Ga.)|December 19, 2017
Procalcitonin and Presepsin as Prognostic Markers After Out-of-Hospital Cardiac ArrestPirkka T Pekkarinen, Giuseppe Ristagno, Erika Wilkman, et al.
Infectious Diseases Now|February 16, 2022
Factors associated with hospital admission and adverse outcome for COVID-19: Role of social factors and medical careA-L Beaumont, D Vignes, R Sterpu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patientsP F Conte, M V Dieci, G Bisagni, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Kidney International|August 1, 1997
Precise quantification of dialysis using continuous sampling of spent dialysate and total dialysate volume measurementA Argilés, A Ficheux, M Thomas, et al.
Shock (Augusta, Ga.)|December 19, 2017
Procalcitonin and Presepsin as Prognostic Markers After Out-of-Hospital Cardiac ArrestPirkka T Pekkarinen, Giuseppe Ristagno, Erika Wilkman, et al.
Infectious Diseases Now|February 16, 2022
Factors associated with hospital admission and adverse outcome for COVID-19: Role of social factors and medical careA-L Beaumont, D Vignes, R Sterpu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patientsP F Conte, M V Dieci, G Bisagni, et al.
Pageof 7